Cargando…
PB1847: A PHASE 1 STUDY TO INVESTIGATE CLN-049, A FLT3/CD3 BISPECIFIC T CELL ENGAGER, IN PATIENTS WITH RELAPSED/REFRACTORY (R/R) ACUTE MYELOID LEUKEMIA (AML) OR MYELODYSPLASTIC SYNDROME (MDS)
| Autores principales: | , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430354/ http://dx.doi.org/10.1097/01.HS9.0000974228.65087.81 |
| _version_ | 1785090943178768384 |
|---|---|
| author | Abdul-Hay, Maher Dinardo, Courtney Chan, Onyee Narayan, Rupa Issa, Ghayas Michaelson, Jennifer Baeuerle, Patrick Meetze, Kristan Janik, John Shapiro, Irina Inumerable, Judy Jones, Jeffery Sallman, David |
| author_facet | Abdul-Hay, Maher Dinardo, Courtney Chan, Onyee Narayan, Rupa Issa, Ghayas Michaelson, Jennifer Baeuerle, Patrick Meetze, Kristan Janik, John Shapiro, Irina Inumerable, Judy Jones, Jeffery Sallman, David |
| author_sort | Abdul-Hay, Maher |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10430354 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104303542023-08-17 PB1847: A PHASE 1 STUDY TO INVESTIGATE CLN-049, A FLT3/CD3 BISPECIFIC T CELL ENGAGER, IN PATIENTS WITH RELAPSED/REFRACTORY (R/R) ACUTE MYELOID LEUKEMIA (AML) OR MYELODYSPLASTIC SYNDROME (MDS) Abdul-Hay, Maher Dinardo, Courtney Chan, Onyee Narayan, Rupa Issa, Ghayas Michaelson, Jennifer Baeuerle, Patrick Meetze, Kristan Janik, John Shapiro, Irina Inumerable, Judy Jones, Jeffery Sallman, David Hemasphere Publication Only Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10430354/ http://dx.doi.org/10.1097/01.HS9.0000974228.65087.81 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Publication Only Abdul-Hay, Maher Dinardo, Courtney Chan, Onyee Narayan, Rupa Issa, Ghayas Michaelson, Jennifer Baeuerle, Patrick Meetze, Kristan Janik, John Shapiro, Irina Inumerable, Judy Jones, Jeffery Sallman, David PB1847: A PHASE 1 STUDY TO INVESTIGATE CLN-049, A FLT3/CD3 BISPECIFIC T CELL ENGAGER, IN PATIENTS WITH RELAPSED/REFRACTORY (R/R) ACUTE MYELOID LEUKEMIA (AML) OR MYELODYSPLASTIC SYNDROME (MDS) |
| title | PB1847: A PHASE 1 STUDY TO INVESTIGATE CLN-049, A FLT3/CD3 BISPECIFIC T CELL ENGAGER, IN PATIENTS WITH RELAPSED/REFRACTORY (R/R) ACUTE MYELOID LEUKEMIA (AML) OR MYELODYSPLASTIC SYNDROME (MDS) |
| title_full | PB1847: A PHASE 1 STUDY TO INVESTIGATE CLN-049, A FLT3/CD3 BISPECIFIC T CELL ENGAGER, IN PATIENTS WITH RELAPSED/REFRACTORY (R/R) ACUTE MYELOID LEUKEMIA (AML) OR MYELODYSPLASTIC SYNDROME (MDS) |
| title_fullStr | PB1847: A PHASE 1 STUDY TO INVESTIGATE CLN-049, A FLT3/CD3 BISPECIFIC T CELL ENGAGER, IN PATIENTS WITH RELAPSED/REFRACTORY (R/R) ACUTE MYELOID LEUKEMIA (AML) OR MYELODYSPLASTIC SYNDROME (MDS) |
| title_full_unstemmed | PB1847: A PHASE 1 STUDY TO INVESTIGATE CLN-049, A FLT3/CD3 BISPECIFIC T CELL ENGAGER, IN PATIENTS WITH RELAPSED/REFRACTORY (R/R) ACUTE MYELOID LEUKEMIA (AML) OR MYELODYSPLASTIC SYNDROME (MDS) |
| title_short | PB1847: A PHASE 1 STUDY TO INVESTIGATE CLN-049, A FLT3/CD3 BISPECIFIC T CELL ENGAGER, IN PATIENTS WITH RELAPSED/REFRACTORY (R/R) ACUTE MYELOID LEUKEMIA (AML) OR MYELODYSPLASTIC SYNDROME (MDS) |
| title_sort | pb1847: a phase 1 study to investigate cln-049, a flt3/cd3 bispecific t cell engager, in patients with relapsed/refractory (r/r) acute myeloid leukemia (aml) or myelodysplastic syndrome (mds) |
| topic | Publication Only |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430354/ http://dx.doi.org/10.1097/01.HS9.0000974228.65087.81 |
| work_keys_str_mv | AT abdulhaymaher pb1847aphase1studytoinvestigatecln049aflt3cd3bispecifictcellengagerinpatientswithrelapsedrefractoryrracutemyeloidleukemiaamlormyelodysplasticsyndromemds AT dinardocourtney pb1847aphase1studytoinvestigatecln049aflt3cd3bispecifictcellengagerinpatientswithrelapsedrefractoryrracutemyeloidleukemiaamlormyelodysplasticsyndromemds AT chanonyee pb1847aphase1studytoinvestigatecln049aflt3cd3bispecifictcellengagerinpatientswithrelapsedrefractoryrracutemyeloidleukemiaamlormyelodysplasticsyndromemds AT narayanrupa pb1847aphase1studytoinvestigatecln049aflt3cd3bispecifictcellengagerinpatientswithrelapsedrefractoryrracutemyeloidleukemiaamlormyelodysplasticsyndromemds AT issaghayas pb1847aphase1studytoinvestigatecln049aflt3cd3bispecifictcellengagerinpatientswithrelapsedrefractoryrracutemyeloidleukemiaamlormyelodysplasticsyndromemds AT michaelsonjennifer pb1847aphase1studytoinvestigatecln049aflt3cd3bispecifictcellengagerinpatientswithrelapsedrefractoryrracutemyeloidleukemiaamlormyelodysplasticsyndromemds AT baeuerlepatrick pb1847aphase1studytoinvestigatecln049aflt3cd3bispecifictcellengagerinpatientswithrelapsedrefractoryrracutemyeloidleukemiaamlormyelodysplasticsyndromemds AT meetzekristan pb1847aphase1studytoinvestigatecln049aflt3cd3bispecifictcellengagerinpatientswithrelapsedrefractoryrracutemyeloidleukemiaamlormyelodysplasticsyndromemds AT janikjohn pb1847aphase1studytoinvestigatecln049aflt3cd3bispecifictcellengagerinpatientswithrelapsedrefractoryrracutemyeloidleukemiaamlormyelodysplasticsyndromemds AT shapiroirina pb1847aphase1studytoinvestigatecln049aflt3cd3bispecifictcellengagerinpatientswithrelapsedrefractoryrracutemyeloidleukemiaamlormyelodysplasticsyndromemds AT inumerablejudy pb1847aphase1studytoinvestigatecln049aflt3cd3bispecifictcellengagerinpatientswithrelapsedrefractoryrracutemyeloidleukemiaamlormyelodysplasticsyndromemds AT jonesjeffery pb1847aphase1studytoinvestigatecln049aflt3cd3bispecifictcellengagerinpatientswithrelapsedrefractoryrracutemyeloidleukemiaamlormyelodysplasticsyndromemds AT sallmandavid pb1847aphase1studytoinvestigatecln049aflt3cd3bispecifictcellengagerinpatientswithrelapsedrefractoryrracutemyeloidleukemiaamlormyelodysplasticsyndromemds |